
Understanding the Perseverance of the Muscular Dystrophy Community One-Year into the COVID-19 Pandemic
Author(s) -
Leann Lewis,
Katy Eichinger,
Nuran Dilek,
Kiley Higgs,
Michaela Walker,
David Palmer,
John Cooley,
Nicholas J. Johnson,
Rabi Tawil,
Jeffrey Statland
Publication year - 2022
Publication title -
journal of neuromuscular diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.366
H-Index - 23
eISSN - 2214-3602
pISSN - 2214-3599
DOI - 10.3233/jnd-220794
Subject(s) - medicine , facioscapulohumeral muscular dystrophy , muscular dystrophy , pandemic , dysferlin , disease , telemedicine , physical therapy , telehealth , covid-19 , myotonic dystrophy , health care , pediatrics , gerontology , infectious disease (medical specialty) , economics , economic growth
In this study, we examined the long-term social and health impacts of the coronavirus disease 2019 (COVID-19) pandemic on people with muscular dystrophy.